170 related articles for article (PubMed ID: 22768734)
21. Alpha-Lipoic Acid for Treatment of Diabetic Peripheral Neuropathy.
Bartkoski S; Day M
Am Fam Physician; 2016 May; 93(9):786. PubMed ID: 27175957
[No Abstract] [Full Text] [Related]
22. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
Androne L; Gavan NA; Veresiu IA; Orasan R
In Vivo; 2000; 14(2):327-30. PubMed ID: 10836205
[TBL] [Abstract][Full Text] [Related]
23. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
Jin HY; Joung SJ; Park JH; Baek HS; Park TS
Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
[TBL] [Abstract][Full Text] [Related]
24. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
Poh ZX; Goh KP
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
[TBL] [Abstract][Full Text] [Related]
25. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS.
Salinthone S; Yadav V; Bourdette DN; Carr DW
Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):132-42. PubMed ID: 18537699
[TBL] [Abstract][Full Text] [Related]
26. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
27. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.
Smith AR; Shenvi SV; Widlansky M; Suh JH; Hagen TM
Curr Med Chem; 2004 May; 11(9):1135-46. PubMed ID: 15134511
[TBL] [Abstract][Full Text] [Related]
28. [Diabetic polyneuropathy. Sequential therapy with alpha-lipoic acid passes the general practice test].
Hedding-Eckerich M; Eckert MW
MMW Fortschr Med; 2000 Sep; 142(36):38. PubMed ID: 11021068
[No Abstract] [Full Text] [Related]
29. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
30. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
31. α-Lipoic acid, diabetic neuropathy, and Nathan's prophecy.
Papanas N; Maltezos E
Angiology; 2012 Feb; 63(2):81-3. PubMed ID: 22253286
[TBL] [Abstract][Full Text] [Related]
32. [Lipoic acid: physiological role and prospects for clinical application].
Tutelyan VA; Makhova AA; Pogozheva AV; Shikh EV; Elizarova EV; Khotimchenko SA
Vopr Pitan; 2019; 88(4):6-11. PubMed ID: 31722135
[TBL] [Abstract][Full Text] [Related]
33. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
[TBL] [Abstract][Full Text] [Related]
34. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy.
Strokov IA; Manukhina EB; Bakhtina LY; Malyshev IY; Zoloev GK; Kazikhanova SI; Ametov AS
Bull Exp Biol Med; 2000 Oct; 130(10):986-90. PubMed ID: 11177301
[TBL] [Abstract][Full Text] [Related]
35. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
36. [Lipoic acid: characteristics and therapeutic application].
Malińska D; Winiarska K
Postepy Hig Med Dosw (Online); 2005; 59():535-43. PubMed ID: 16407792
[TBL] [Abstract][Full Text] [Related]
37. Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.
Ibrahimpasic K
Med Arch; 2013; 67(1):7-9. PubMed ID: 23678828
[TBL] [Abstract][Full Text] [Related]
38. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
[TBL] [Abstract][Full Text] [Related]
39. Potential of nonoral α-lipoic acid aqueous formulations to reduce ocular microvascular complications in a streptozotocin-induced diabetic rat model.
Chen CL; Cheng WS; Chen JL; Chiang CH
J Ocul Pharmacol Ther; 2013 Oct; 29(8):738-45. PubMed ID: 23848951
[TBL] [Abstract][Full Text] [Related]
40. Potential for Novel Therapeutic Uses of Alpha Lipoic Acid.
Fasipe B; Faria A; Laher I
Curr Med Chem; 2023; 30(35):3942-3954. PubMed ID: 36201272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
